Rigaku Publishes EDXRF Method for Iron in Ore... (Austin TX (PRWEB) February 20 2013 Ap...)

Rigaku Publishes EDXRF Method for Iron in Ore Materials

Date:2/20/2013

Austin, TX (PRWEB) February 20, 2013

Applied Rigaku Technologies, Inc. today announced a new empirical method for the elemental analysis and measurement of iron (Fe) in mining materials.

Elemental analysis is essential in screening samples at mine sites and throughout the processing of ores, ensuring proper extraction and process control. Major and minor elements are also closely monitored in the ore, concentrates, slags and tails during smelting.

Rigaku EDXRF Application Note #1286 demonstrates the effectiveness of low cost energy dispersive X-ray fluorescence (EDXRF) analysis for elemental analysis of metals in ore samples. The new method demonstrates the capabilities of the Rigaku NEX QC EDXRF elemental analyzer in meeting industry demands for a fast and simple technique suitable for measurement along the entire processing line. The report provides details of sample preparation, calibration and repeatability.

For the analysis described in the report, material was ground and dried to a homogeneous powder, which was then prepared by filling a standard 32 mm XRF measurement cell and compacting with a manual sample press. Analysis was carried out using the NEX QC EDXRF analyzer, which utilizes 50 kV direct excitation and a high performance semiconductor detector to provide enhanced sensitivity in a low cost tool ideal for the analysis of ore materials. The NEX QC analyzer is designed to be easily transportable for mine site screening, rugged enough for the smelting operations, and powerful enough for work in a central lab.

The results of the study indicate that the NEX QC EDXRF analyzer is an optimal tool for identifying and quantifying elemental composition of a wide variety of iron materials. With a small footprint and modern touch screen interface, the Rigaku NEX QC analyzer is transportable, rugged and reliable, and ideal for use in iron production.

Request a copy of the report:
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Rigaku ZSX Primus Application Note: Lubricating Oil Analysis by WDXRF According to ASTM D6443-04
2. Rigaku Publishes New Application Note: Cement Raw Meal Analysis by Pressed Powder Method on the ZSX Primus III+
3. Rigaku Publishes New Method for Sulfur Analysis of Petroleum Products by WDXRF According to ASTM D2622-10
4. Rigaku Publishes New Application for Cement Analysis by the Pressed Powder Method on the ZSX Primus III+ According to ASTM C114-11
5. Rigaku Publishes Application Note for Low Concentration Sulfur in Petroleum-based Fuels by WDXRF According to ASTM D2622-10
6. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
7. Rigaku Application Note: Silicate Rock Analysis by Fusion Method
8. Rigaku Publishes New Application Note for Quantitative Analysis of Stainless Steel
9. Rigaku Publishes method for Determination of Sulfur in Bio-gasoline
10. Rigaku publishes new WDXRF Application: Determination of Metals in Copper Concentrate by Advanced Correction Method for Fused Beads
11. Rigaku Announces Method for Quantitative Elemental Analysis of Low-Alloy Steel with the Rigaku ZSX Primus III+ WDXRF Spectrometer

Post Your Comments:

(Date:6/19/2013)... A new look at “big glass” ... trends will highlight technical sessions at SPIE Photomask ... its 33rd year, the three-day event is the industry’s ... suppliers, approximately 100 technical presentations and numerous networking lunches ... for optics and photonics , the meeting will be ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the fourth quarter and full year ... Fourth Quarter of Fiscal 2013 Highlights ... increased by 33.3% to RMB133.0 million ($21.4 million) from ...

(Date:6/18/2013)... FL (PRWEB) June 18, 2013 The human ... the skin as an important human body part. Similar to ... for in order to function, repair and grow. Recent reports ... vitamins and supplements, is just as important as other life ... supplements to aid in skin cell reproduction, increase the appearance ...

(Date:6/18/2013)... 2013 regulated information — Global biopharmaceutical company UCB, ... announced the launch of a new Pledge campaign for ... The Pledge empowers the millions of Americans ... a personal commitment to demand more: greater understanding of ... and additional partial-onset seizure control. More information is available ...

[0] ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin [0] Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy

... WOODLANDS, Texas, Nov. 5, 2010 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... and reported financial results for the three and nine ... established proof-of-concept for two new mechanisms of action in ...

... Patricia Thiel of Iowa State University and the Ames Laboratory ... coasters to the middle and a trinket box to the left. ... of little things." So Thiel grabbed the smaller things and slid ... "Nature wants one big thing all together, like this." Thiel, ...

... Science, Inc. (OTC Bulletin Board: CBIS ), ... announced today that regardless of the outcome of Proposition ... the country, it is apparent that that the Cannabis ... ever, as the demand for the Cannabis Science Pharmaceutical ...

Cached Biology Technology:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 2 Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 3 Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 4 Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 5 Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 6 Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 7 Iowa State, Ames Laboratory scientists advance the understanding of the big getting bigger 2 Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 2 Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 3

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results Iowa State, Ames Laboratory scientists advance the understanding of the big getting bigger Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately

(Date:6/18/2013)... at the University of Calgary,s Faculty of Medicine have ... body from harmful bacteria. Platelets, a component of blood ... for specific bacteria, and upon detection, seal it off ... were published in Nature Immunology this week, ... immunity. , "The science community has known that platelets ...

(Date:6/18/2013)... Research Council, Laboratory of Molecular Biology, has been ... Young Investigator Award. Torrent is being recognized for ... algorithm to predict antimicrobial regions in proteins. Luis ... now applying this algorithm to interrogate full genomes ... with very appealing results." , Torrent obtained ...

(Date:6/18/2013)... between 5% and 10% of breast and ovarian cancers ... these tumours are attributable to inherited mutations from the ... patients with these mutations, PARP inhibitors, which are currently ... them a new option for personalised cancer treatment, an ... that a fraction of these patients generate resistance to ...

Breaking Biology News(10 mins):Immunity mechanism discovered 2 The American Society for Microbiology honors Marc Torrent 2 An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2

[0] Immunity mechanism discovered [0] The American Society for Microbiology honors Marc Torrent [0] An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer

... buy large quantities of anthrax, in a controversial move that ... designed to limit the spread of biological weapons. , A ... the US army' Dugway Proving Ground in Utah. They ask ... a non-virulent strain of anthrax, and for equipment to produce ...

... to the deadly skin cancer melanoma, studying functional ... insight into the disease's development, according to new ... fellow at Stanford University School of Medicine. , ... development, scientists have not been able to establish ...

... findings and statistically significant improvements in clinical measures ... on the Etiology, Pathogenesis and Treatment of Parkinson's ... showed positive interim results in patients with Parkinson's ... a statistically significant improvement in motor function on ...

Cached Biology News:US Army plans to bulk-buy anthrax 2 Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 2 Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 3 Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 2 Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 3 Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 4 Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 5 Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 6

US Army plans to bulk-buy anthrax Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease

RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein...

RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...

Request Info...

Biology Products:

Equine IL-4 from AbD Serotec Equine TNF ALPHA from AbD Serotec RayBio Human Inflammation Antibody Array III & 3.1 Service from Raybiotech, Inc.Feline IL-10 ELISpot Development Kit from R&D Systems